Alabama Medicaid Agency PDL quarterly updates

Author: APCI Staff/Tuesday, December 30, 2014/Categories: APCI News, APCI Choice

Effective January 5, 2015, the Alabama Medicaid Agency will:

  1. Require prior authorization for payment of atovaquone oral suspension (generic Mepron oral suspension). Brand Mepron oral suspension will be preferred with no PA.
    • Use Dispense as Written (DAW) Code of 9 for brand Mepron oral suspension. DAW Code of 9 indicates the following: Substitution Allowed by Prescriber but Plan Requests Brand - Patient's Plan Requested Brand Product to be Dispensed.
  2. Update the Preferred Drug List (PDL) to reflect the quarterly updates. The updates are listed below:
PDL Additions
Humalog Mix 50-50 Anti-diabetic Agents/Insulins
Humalog Mix 75-25 Anti-diabetic Agents/Insulins
Mepron Anti-infective Agents/Antiprotozoals, Miscellaneous
Novolog Anti-diabetic Agents/Insulins
Novolog Mix 70-30 Anti-diabetic Agents/Insulins
PDL Deletions
Gris-Peg Anti-infective Agents/Antifungals, Miscellaneous
Infergen Anti-infective Agents/Interferons

For more information, visit the Alabama Medicaid announcement by clicking here or download the PDF file listed below.

Comments are only visible to subscribers.